TWD 52.1
(-1.14%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 2.75 Billion TWD | -16.95% |
2022 | 3.3 Billion TWD | -13.09% |
2021 | 3.79 Billion TWD | 27.9% |
2020 | 2.96 Billion TWD | 20.27% |
2019 | 2.46 Billion TWD | 91.95% |
2018 | 1.28 Billion TWD | 4.77% |
2017 | 1.22 Billion TWD | 106.14% |
2016 | 595.69 Million TWD | -74.6% |
2015 | 2.34 Billion TWD | 41.27% |
2014 | 1.65 Billion TWD | 110.61% |
2013 | 788.17 Million TWD | -28.26% |
2012 | 1.09 Billion TWD | 144.5% |
2011 | 449.33 Million TWD | -46.97% |
2010 | 847.33 Million TWD | -52.22% |
2009 | 1.77 Billion TWD | 359.25% |
2008 | 386.12 Million TWD | 35.48% |
2007 | 285 Million TWD | 2.27% |
2006 | 278.67 Million TWD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | 122.77 Million TWD | -32.05% |
2024 Q2 | 241.6 Million TWD | 96.79% |
2023 Q4 | 180.69 Million TWD | -75.53% |
2023 FY | 2.74 Billion TWD | -16.95% |
2023 Q1 | 634.43 Million TWD | 9.47% |
2023 Q2 | 2.76 Billion TWD | 335.89% |
2023 Q3 | 738.46 Million TWD | -73.3% |
2022 Q1 | 972.79 Million TWD | 9.87% |
2022 FY | 3.3 Billion TWD | -13.09% |
2022 Q4 | 579.54 Million TWD | -26.57% |
2022 Q3 | 789.28 Million TWD | -17.76% |
2022 Q2 | 959.71 Million TWD | -1.34% |
2021 Q3 | 984.67 Million TWD | 0.34% |
2021 Q2 | 981.38 Million TWD | 3.63% |
2021 FY | 3.79 Billion TWD | 27.9% |
2021 Q1 | 947.01 Million TWD | 111.59% |
2021 Q4 | 885.4 Million TWD | -10.08% |
2020 Q3 | 611.38 Million TWD | 27.82% |
2020 Q4 | 447.57 Million TWD | -26.79% |
2020 Q1 | 1.43 Billion TWD | 135.73% |
2020 Q2 | 478.33 Million TWD | -66.61% |
2020 FY | 2.96 Billion TWD | 20.27% |
2019 Q1 | 673.66 Million TWD | -29.11% |
2019 Q3 | 559.16 Million TWD | -11.09% |
2019 Q4 | 607.73 Million TWD | 8.69% |
2019 FY | 2.46 Billion TWD | 91.95% |
2019 Q2 | 628.91 Million TWD | -6.64% |
2018 Q2 | 787.41 Million TWD | 51.86% |
2018 Q4 | 950.28 Million TWD | 36.96% |
2018 FY | 1.28 Billion TWD | 4.77% |
2018 Q1 | 518.5 Million TWD | 160.2% |
2018 Q3 | 693.83 Million TWD | -11.88% |
2017 Q1 | 618.5 Million TWD | 211.96% |
2017 FY | 1.22 Billion TWD | 106.14% |
2017 Q4 | 199.27 Million TWD | -56.51% |
2017 Q3 | 458.18 Million TWD | -17.98% |
2017 Q2 | 558.63 Million TWD | -9.68% |
2016 Q1 | 88.22 Million TWD | -91.35% |
2016 FY | 595.69 Million TWD | -74.6% |
2016 Q2 | 288.29 Million TWD | 226.76% |
2016 Q3 | 161.91 Million TWD | -43.84% |
2016 Q4 | -552.42 Million TWD | -441.18% |
2015 Q1 | 23.42 Million TWD | -99.1% |
2015 FY | 2.34 Billion TWD | 41.27% |
2015 Q4 | 1.02 Billion TWD | -17.13% |
2015 Q3 | 1.23 Billion TWD | 373.92% |
2015 Q2 | 259.71 Million TWD | 1008.72% |
2014 Q3 | 132.98 Million TWD | 136.34% |
2014 FY | 1.65 Billion TWD | 110.61% |
2014 Q1 | 112.93 Million TWD | 160.94% |
2014 Q2 | 56.27 Million TWD | -50.17% |
2014 Q4 | 2.59 Billion TWD | 1850.35% |
2013 Q3 | 257.53 Million TWD | 522.09% |
2013 Q4 | -185.3 Million TWD | -171.95% |
2013 Q1 | 2.52 Billion TWD | 104.36% |
2013 Q2 | 41.39 Million TWD | -98.36% |
2013 FY | 788.17 Million TWD | -28.26% |
2012 Q4 | 1.23 Billion TWD | 36.94% |
2012 FY | 1.09 Billion TWD | 144.5% |
2012 Q1 | -35.82 Million TWD | -117.54% |
2012 Q2 | 770.14 Million TWD | 2249.57% |
2012 Q3 | 901.78 Million TWD | 17.09% |
2011 Q2 | 226.44 Million TWD | -30.32% |
2011 FY | 449.33 Million TWD | -46.97% |
2011 Q4 | 204.2 Million TWD | 86.17% |
2011 Q3 | 109.69 Million TWD | -51.56% |
2011 Q1 | 324.99 Million TWD | 19.22% |
2010 FY | 847.33 Million TWD | -52.22% |
2010 Q4 | 272.59 Million TWD | 30.52% |
2010 Q3 | 208.86 Million TWD | -8.41% |
2010 Q2 | 228.04 Million TWD | -6.94% |
2010 Q1 | 245.04 Million TWD | 0.0% |
2009 FY | 1.77 Billion TWD | 359.25% |
2008 FY | 386.12 Million TWD | 35.48% |
2007 FY | 285 Million TWD | 2.27% |
2006 FY | 278.67 Million TWD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Sinon Corporation | 1.42 Billion TWD | -93.95% |
All Cosmos Bio-Tech Holding Corporation | 189.89 Million TWD | -1352.189% |
CH Biotech R&D Co., Ltd. | 594.67 Million TWD | -363.725% |